Eli Lilly to buy Centessa in $6.3 billion deal for sleep medicines

Eli Lilly is acquiring Centessa Pharmaceuticals for approximately $6.3 billion, with an additional contingent value right potentially increasing the deal to $7.8 billion. This strategic move aims to bolster Lilly's offerings in the sleep-wake disorder treatment market. Centessa's shares saw a significant surge following the announcement.